New pill shows promise for Hard-to-Treat cancers with BRAF mutation
NCT ID NCT05355701
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This early-stage trial is testing a new oral drug, PF-07799933, in people aged 16 and older with advanced solid tumors that have a specific BRAF gene change. The drug is given alone or combined with other medicines like binimetinib or cetuximab. The study aims to find safe doses and see if the drug can shrink tumors. About 267 participants will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PF-07799933 (ARRY-440) tablet, taken twice daily, alone or with binimetinib, cetuximab, or chemotherapy
What this could lead to
If successful, this could lead to a new treatment option for people with advanced solid tumors that have a BRAF gene change and have stopped responding to other therapies.
What could go wrong
This is an early Phase 1 trial focused mainly on safety and dosing, so it is too soon to know if the drug will effectively shrink tumors. Side effects are possible and will be closely monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Brigitte Harris Cancer Pavilion
RECRUITINGDetroit, Michigan, 48202, United States
-
CT Scan and Echo Only: Henry Ford Medical Center-Plymouth
RECRUITINGPlymouth, Michigan, 48170, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy
RECRUITINGCleveland, Ohio, 44106, United States
-
Clinical and Translational Research Center (CTRC)
RECRUITINGAurora, Colorado, 80045, United States
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute - Chestnut Hill
RECRUITINGNewton, Massachusetts, 02467, United States
-
Hadassah Medical Center
RECRUITINGJerusalem, 9112001, Israel
-
Henry Ford Hospital
RECRUITINGDetroit, Michigan, 48202, United States
-
Henry Ford Medical Center - Columbus
RECRUITINGNovi, Michigan, 48377, United States
-
Highlands Oncology Group
RECRUITINGFayetteville, Arkansas, 72703, United States
-
Highlands Oncology Group
RECRUITINGRogers, Arkansas, 72758, United States
-
Highlands Oncology Group
RECRUITINGSpringdale, Arkansas, 72762, United States
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
MSK David H. Koch Center for Cancer Care
RECRUITINGNew York, New York, 10021, United States
-
MSK Monmouth
RECRUITINGMiddletown, New Jersey, 07748, United States
-
McGill University Health Centre
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center 53rd street
RECRUITINGNew York, New York, 10022, United States
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 1X6, Canada
-
Providence Cancer Institute Franz Clinic
RECRUITINGPortland, Oregon, 97213, United States
-
Providence Portland Medical Center
RECRUITINGPortland, Oregon, 97213, United States
-
Rambam Health Care Campus
RECRUITINGHaifa, Ḥeifā, 3109601, Israel
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Sarah Cannon Research Institute - Pharmacy
RECRUITINGNashville, Tennessee, 37203, United States
-
Sheba Medical Center
RECRUITINGRamat Gan, 5262000, Israel
-
Sourasky Medical Center
RECRUITINGTel Aviv, Central District, 6423906, Israel
-
Sylvester Comprehensive Cancer Center
RECRUITINGMiami, Florida, 33136, United States
-
The Ottawa Hospital - General Campus
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
TriStar Bone Marrow Transplant
RECRUITINGNashville, Tennessee, 37203, United States
-
TriStar Centennial Medical Center - Cell Processing Lab
RECRUITINGNashville, Tennessee, 37203, United States
-
TriStar Centennial Medical center
RECRUITINGNashville, Tennessee, 37203, United States
-
UCHealth Sue Anschutz-Rodgers Eye Center
RECRUITINGAurora, Colorado, 80045, United States
-
University Health Network
RECRUITINGToronto, Ontario, M5G 2C4, Canada
-
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP)
RECRUITINGAurora, Colorado, 80045, United States
-
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)
RECRUITINGAurora, Colorado, 80045, United States
-
University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)
RECRUITINGAurora, Colorado, 80045, United States
-
University of Miami Hospital and Clinics
RECRUITINGMiami, Florida, 33136, United States